Breast Carcinoma In Situ
Showing 9976 - 10000 of >10,000
BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Petah-Tikva (DIM-Avail 100mg)
Completed
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
- DIM-Avail 100mg
-
Petah-Tikva, IsraelRabin Medical Center, Beilinson Hospital
Nov 9, 2020
Renal Cell Carcinoma Trial in Hamilton, Toronto (SBRT)
Active, not recruiting
- Renal Cell Carcinoma
- SBRT
-
Hamilton, Ontario, Canada
- +1 more
Dec 15, 2020
Obesity Trial in Korea, Republic of, Thailand (Semaglutide 2.4 mg, Placebo (semaglutide 2.4 mg))
Not yet recruiting
- Obesity
- Semaglutide 2.4 mg
- Placebo (semaglutide 2.4 mg)
-
Daejeon, Korea, Republic of
- +7 more
Apr 6, 2022
Colorectal Cancer Metastatic, Liver Metastases Trial in Jena, Tübingen (Living donor liver transplantation with two-staged
Recruiting
- Colorectal Cancer Metastatic
- Liver Metastases
- Living donor liver transplantation with two-staged hepatectomy.
-
Jena, Germany
- +1 more
Mar 28, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Apatinib)
Not yet recruiting
- Nasopharyngeal Carcinoma
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Sep 7, 2020
Could Docosahexaenoic Acid, Contained in Breast Milk and
Not yet recruiting
- COVID19
- (no location specified)
Oct 7, 2021
Esophageal Squamous Cell Carcinoma Trial in Guangzhou (SMART, DDP, S-1)
Completed
- Esophageal Squamous Cell Carcinoma
- SMART
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Sep 2, 2020
Endometrial Cancer Trial in Lausanne (Lymphatic drainage of endometrial cancer)
Recruiting
- Endometrial Cancer
- Lymphatic drainage of endometrial cancer
-
Lausanne, SwitzerlandCHUV department of gynecology
Jan 25, 2021
Triple Negative Breast Cancer Trial in El Segundo (drug, biological, procedure)
Active, not recruiting
- Triple Negative Breast Cancer
- Aldoxorubicin HCl
- +17 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Breast Cancer Female, Early-stage Breast Cancer, Lymph Node Metastases Trial in Montreal (Targeted Axillary Dissection,
Recruiting
- Breast Cancer Female
- +4 more
- Targeted Axillary Dissection
- Ultrasound of the axilla
-
Montreal, Quebec, Canada
- +1 more
May 19, 2021
Thrombin Generation by ST Genesia System
Not yet recruiting
- Patients Without a Medical History of Thrombosis or Hemorrhage
- +4 more
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 13, 2022
Breast Cancer, Acute Pain, Anesthesia Trial in Ottawa (PVB group, MTP block group, Control Group)
Recruiting
- Breast Cancer
- +2 more
- PVB group
- +2 more
-
Ottawa, Ontario, CanadaThe Ottawa Hospital
Aug 11, 2021
Liver Cirrhosis, Hepatocellular Carcinoma, HIV Trial in Spain
Completed
- Liver Cirrhosis
- +3 more
-
La Línea de la Concepción, Cádiz, Spain
- +7 more
Feb 24, 2021
Breast Tumors Trial in Mumbai (500 mg of depot hydroxy-progesterone)
Completed
- Breast Neoplasms
- 500 mg of depot hydroxy-progesterone
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
Jul 21, 2020
D2 Versus D1 Gastrectomy of Operable Gastric Cancer
Completed
- Gastric Cancer
- Radical gastrectomy with D1 lymphadenectomy
- Radical gastrectomy with D2 lymphadenectomy
-
Alexandria, Egypt(unnamed)
Jun 10, 2020
Breast Tumors, Radiotherapy Side Effect Trial in Nanchang (customized 3D-printed bolus fabricated based on reconstruction of
Recruiting
- Breast Neoplasms
- Radiotherapy Side Effect
- customized 3D-printed bolus fabricated based on reconstruction of computed tomography (CT) images
-
Nanchang, Jiangxi, ChinaJiangxi Cancer Hospital of Nanchang University
Apr 14, 2021
Breast Cancer, Chemo-induced Alopecia Trial in Keelung (low-level light therapy)
Recruiting
- Breast Cancer
- Chemotherapy-induced Alopecia
- low-level light therapy
-
Keelung, TaiwanKeelung Chang Gung Memorial Hospital
Jul 18, 2022
Breast Cancer Trial in Beijing (apatinib+oral etoposide)
Completed
- Breast Cancer
- apatinib+oral etoposide
-
Beijing, Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Dec 1, 2020
Breast Cancer, Triple Negative Breast Cancer, Hormone Receptor Negative Tumor Trial in Leuven (Pembrolizumab)
Completed
- Breast Cancer
- +2 more
-
Leuven, BelgiumUniversity Hospitals Leuven
May 18, 2021
Multiple Sclerosis Trial in Worldwide (ponesimod, teriflunomide)
Completed
- Multiple Sclerosis
-
Carlsbad, California
- +161 more
Jan 24, 2022
Head and Neck Squamous Cell Carcinoma Trial in Dalian (Raltitrexed, Intensity Modulated Radiotherapy)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Raltitrexed
- Intensity Modulated Radiotherapy
-
Dalian, Liaoning, ChinaLv Xiupeng
Aug 5, 2020